Ora signs on CRO industry expert Paul Colvin as COO

12 Apr 2023
www.fiercebiotech.com
Executive Change
Ora signs on CRO industry expert Paul Colvin as COO
Preview
Source: FierceBiotech
CRO industry executive Paul Colvin has been named Ora's new chief operating officer to help lead the ophthalmology specialist's global growth.
Ora has brought on industry expert Paul Colvin as its new chief operating officer to help lead the ophthalmology CRO’s global growth.
Colvin brings more than 30 years experience in the industry with a 14-year stint at Eli Lilly and 12 years leading PPD’s clinical development business, the company said in an April 6 press release. More recently, he held the positions of president of clinical development solutions and chief business officer at Syneos Health. Colvin started his career as a pharmacist.
At Ora, Colvin will report directly to CEO Stuart Abelson.
Andover, Massachusetts-based Ora focuses on ophthalmic treatments for dry eye and glaucoma, allergy, medical devices, anti-infective and anti-inflammatories.
In November, the company inked a deal with the U.K. nonprofit Macular Society to continue to support the advancement of new treatment options in eye care across Great Britain.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.